Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Monash IVF Group stock

MVF.AX
AU000000MVF3
A116LZ

Price

1.22 AUD
Today +/-
-0.02 AUD
Today %
-2.44 %

Monash IVF Group stock price

AUD
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Monash IVF Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Monash IVF Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Monash IVF Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Monash IVF Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Monash IVF Group Stock Price History

DateMonash IVF Group Price
1/9/20251.22 AUD
1/8/20251.26 AUD
1/7/20251.27 AUD
1/6/20251.27 AUD
1/3/20251.27 AUD
1/2/20251.27 AUD
12/31/20241.28 AUD
12/30/20241.27 AUD
12/27/20241.26 AUD
12/24/20241.24 AUD
12/23/20241.26 AUD
12/20/20241.23 AUD
12/19/20241.22 AUD
12/18/20241.24 AUD
12/17/20241.25 AUD
12/16/20241.23 AUD
12/13/20241.26 AUD
12/12/20241.25 AUD
12/11/20241.23 AUD

Monash IVF Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Monash IVF Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Monash IVF Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Monash IVF Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Monash IVF Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Monash IVF Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Monash IVF Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Monash IVF Group’s growth potential.

Monash IVF Group Revenue, EBIT and net profit per share

DateMonash IVF Group RevenueMonash IVF Group EBITMonash IVF Group Net Income
2027e312.06 M AUD58.37 M AUD36.64 M AUD
2026e296.81 M AUD54.22 M AUD33.84 M AUD
2025e280.23 M AUD49.77 M AUD31.65 M AUD
2024254.96 M AUD-5.61 M AUD-6.53 M AUD
2023213.59 M AUD33.12 M AUD21.84 M AUD
2022192.29 M AUD28.37 M AUD18.41 M AUD
2021183.61 M AUD38.65 M AUD25.33 M AUD
2020145.42 M AUD21.83 M AUD11.73 M AUD
2019151.98 M AUD32.74 M AUD19.85 M AUD
2018150.64 M AUD33.16 M AUD21.35 M AUD
2017155.18 M AUD44.61 M AUD29.62 M AUD
2016156.56 M AUD45.37 M AUD28.78 M AUD
2015124.96 M AUD37.9 M AUD21.37 M AUD
2014114 M AUD35.9 M AUD2.6 M AUD
201396.6 M AUD30.5 M AUD-14.9 M AUD
201293.2 M AUD23.8 M AUD-15.3 M AUD
201183.5 M AUD19.8 M AUD-13.4 M AUD
201075.8 M AUD2.1 M AUD-23.1 M AUD

Monash IVF Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M AUD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M AUD)NET INCOME (M AUD)NET INCOME GROWTH (%)DIV. (AUD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
2010201120122013201420152016201720182019202020212022202320242025e2026e2027e
75839396114124156155150151145183192213254280296312
-10.6712.053.2318.758.7725.81-0.64-3.230.67-3.9726.214.9210.9419.2510.245.715.41
92.0093.9892.4792.7189.4789.5291.0391.6190.6790.0788.9789.0789.5889.6789.7681.4377.0373.08
69788689102111142142136136129163172191228000
-23-13-15-142212829211911251821-6313336
--43.4815.38-6.67-114.29950.0033.333.57-27.59-9.52-42.11127.27-28.0016.67-128.57-616.676.459.09
------------------
------------------
231.1231.1231.1231.1231.1248.47253.16253.03252.44252.62258.1390.94391.54392.43389.63000
------------------
Details

Keystats

Revenue and Growth

The Monash IVF Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Monash IVF Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M AUD)RECEIVABLES (M AUD)OTHER REC. (M AUD)INVENTORIES (M AUD)OTHER CURRENT LIAB. (M AUD)CURRENT ASSETS (M AUD)TANGIBLE ASSETS (M AUD)LONG-T. INVEST. (M AUD)LONG-T. REC. (M AUD)INTANGIBLE ASSETS (M AUD)GOODWILL (M AUD)OTHER NON-CURRENT ASSETS (M AUD)NON-CURRENT ASSETS (M AUD)TOTAL ASSETS (M AUD)LIABILITIESCOMMON STOCK (M AUD)ADDITIONAL PAID-IN CAPITAL (M AUD)RETAINED EARNINGS (M AUD)OTHER EQUITY (M AUD)UNREAL. GAINS/LOSSES (M AUD)EQUITY (M AUD)LIABILITIES (M AUD)PROVISIONS (M AUD)OTHER SHORT-TERM LIAB. (M AUD)SHORT-TERM DEBTS (M AUD)LONG-TERM DEBT PORTION (M AUD)SHORT-TERM REC. (M AUD)LONG-T. LIAB. (M AUD)DEFERRED TAXES (M AUD)OTHER LIAB. (M AUD)LONG-T. LIABILITIES (M AUD)DEBT (M AUD)TOTAL CAPITAL (M AUD)
201020112012201320142015201620172018201920202021202220232024
                             
14.920.329.640.68.89.998.473.53.854.2815.078.767.878.0111.33
4.342.82.92.72.513.583.943.592.894.54.534.785.997.21
4.12.11.40.30.30.60.871.143.182.064.392.053.674.5423.38
1.80.60.5000003.853.983.954.225.256.438.18
4.12.62.42.32.83.74.886.482.252.332.762.944.064.985.68
29.229.636.746.114.616.817.8115.0516.7315.5330.6622.525.6429.9455.78
33.940.729.96.79.114.4715.2416.7516.9416.5255.6367.2995.06109.39138.11
0.30.30.3000.10.10.650.750.760.390.941.051.281.59
3.82.93.23.20.40.420.410.110.090.110.180.460.170.170.17
29.125.623.922.52221.7524.8425.5827282926.125.7225.3223.97
182180.5181.5186.6197.7229.11229.11229.11229.11229.11233.17233.17233.17255.13273.35
9.18.81.80.52.60.400000000.6815.49
258.2258.8240.6219.5231.8266.25269.71272.2273.89274.5318.36327.97355.17391.96452.69
287.4288.4277.3265.6246.4283.05287.52287.25290.61290.04349.03350.47380.82421.89508.47
                             
40.648.849.549.5422.6428.35428.35428.35428.35428.76506.79506.79506.79506.79506.79
000000000000000
-24.5-36.9-51.6-63.1-160.9-147.51-136.66-128.02-124.94-118.73-120.17-103.79-102.06-96.77-127.77
000-0.2-136.9-136.81-136.81-136.81-136.81-136.81-136.81-136.81-136.81-136.81-137.11
000000000000000
16.111.9-2.1-13.8124.8144.03154.87163.52166.59173.22249.81266.19267.92273.2241.91
2.42.11.31.21.32.083.813.752.84.393.022.253.341.863.08
4.94.68.99.113.615.2413.5113.6712.7113.3320.2519.7318.1122.1326.45
12.48.611.78.39.214.3918.827.546.466.4912.2811.649.616.1981.31
000000000000000
7.954.44.81030000002.327.477.136.337.99
27.669.726.7121.624.131.7136.1424.9621.9724.237.8641.0838.1846.5118.82
269.7220.4279.3181.296106.2694.5595.1597.688.3555.2638.5270.193.71127.38
11.813.62.49.1000.721.692.882.191.550.560.7300
-1.821.50.71.31.061.241.951.311.862.241.871.926.6115.61
279.7236283.219197.3107.3296.598.78101.7892.459.0540.9472.75100.32142.99
307.3305.7309.9312.6121.4139.03132.64123.74123.75116.696.9182.02110.93146.82261.81
323.4317.6307.8298.8246.2283.05287.52287.25290.35289.82346.72348.21378.84420.02503.72
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Monash IVF Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Monash IVF Group's financial health and stability.

Assets

Monash IVF Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Monash IVF Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Monash IVF Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Monash IVF Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M AUD)DEPRECIATION (M AUD)DEFERRED TAXES (M AUD)CHANGES IN WORKING CAPITAL (M AUD)NON-CASH ITEM (M AUD)PAID INTEREST (M AUD)PAID TAXES (k AUD)NET CASH FLOW FROM OPERATING ACTIVITIES (M AUD)CAPITAL EXPENDITURES (M AUD)CASH FLOW FROM INVESTING ACTIVITIES (M AUD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M AUD)INTEREST INCOME AND EXPENSES (M AUD)NET DEBT CHANGE (M AUD)NET CHANGE IN EQUITY (M AUD)CASH FLOW FROM FINANCING ACTIVITIES (M AUD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M AUD)TOTAL DIVIDENDS PAID (M AUD)NET CHANGE IN CASH FLOW (M AUD)FREE CASH FLOW (M AUD)SHARE-BASED COMPENSATION (M AUD)
20102011201220132014201520162017201820192020202120222023
000000000000021
000000000000012
00000000000000
00000000003700
00000000000003
-13-12-1200000000000
-2,0001,0000-6,000-1,000-4,000-4,000-20,000-9,000-6,000-4,000-7,000-9,000-9,000
-133203036364425253331433139
-29-26-2-3-3-5-8-6-6-6-7-9-11-27
-828016-216-29-10-7-6-6-10-11-15-40
-5234219-212-23-2000-3-1-3-12
00000000000000
59-15-10-23-8410-1202-9-76-25019
4000301-3000077000
96-6-10-35148-5-34-23-19-26-9-39-171
3380-10-41-5-4-3-3-3-300-1
000-2-26-7-18-20-18-13-7-13-16-17
22043475414741354042373948
-43.35-22.5417.7426.8132.430.4835.9619.3119.3726.5623.5734.0220.1311.33
00000000000000

Monash IVF Group stock margins

The Monash IVF Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Monash IVF Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Monash IVF Group.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Monash IVF Group's sales revenue. A higher gross margin percentage indicates that the Monash IVF Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Monash IVF Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Monash IVF Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Monash IVF Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Monash IVF Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Monash IVF Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Monash IVF Group Margin History

Monash IVF Group Gross marginMonash IVF Group Profit marginMonash IVF Group EBIT marginMonash IVF Group Profit margin
2027e89.57 %18.7 %11.74 %
2026e89.57 %18.27 %11.4 %
2025e89.57 %17.76 %11.29 %
202489.57 %-2.2 %-2.56 %
202389.51 %15.51 %10.22 %
202289.71 %14.75 %9.57 %
202189.17 %21.05 %13.8 %
202088.72 %15.01 %8.06 %
201989.77 %21.54 %13.06 %
201890.36 %22.01 %14.18 %
201791.59 %28.75 %19.09 %
201690.8 %28.98 %18.38 %
201589.59 %30.33 %17.1 %
201490 %31.49 %2.28 %
201392.24 %31.57 %-15.42 %
201293.24 %25.54 %-16.42 %
201193.41 %23.71 %-16.05 %
201091.69 %2.77 %-30.47 %

Monash IVF Group Stock Sales Revenue, EBIT, Earnings per Share

The Monash IVF Group earnings per share therefore indicates how much revenue Monash IVF Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Monash IVF Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Monash IVF Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Monash IVF Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Monash IVF Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Monash IVF Group Revenue, EBIT and net profit per share

DateMonash IVF Group Sales per ShareMonash IVF Group EBIT per shareMonash IVF Group Earnings per Share
2027e0.8 AUD0 AUD0.09 AUD
2026e0.76 AUD0 AUD0.09 AUD
2025e0.72 AUD0 AUD0.08 AUD
20240.65 AUD-0.01 AUD-0.02 AUD
20230.54 AUD0.08 AUD0.06 AUD
20220.49 AUD0.07 AUD0.05 AUD
20210.47 AUD0.1 AUD0.06 AUD
20200.56 AUD0.08 AUD0.05 AUD
20190.6 AUD0.13 AUD0.08 AUD
20180.6 AUD0.13 AUD0.08 AUD
20170.61 AUD0.18 AUD0.12 AUD
20160.62 AUD0.18 AUD0.11 AUD
20150.5 AUD0.15 AUD0.09 AUD
20140.49 AUD0.16 AUD0.01 AUD
20130.42 AUD0.13 AUD-0.06 AUD
20120.4 AUD0.1 AUD-0.07 AUD
20110.36 AUD0.09 AUD-0.06 AUD
20100.33 AUD0.01 AUD-0.1 AUD

Monash IVF Group business model

The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group is one of the most popular companies on Eulerpool.com.

Monash IVF Group SWOT Analysis

Strengths

Monash IVF Group Ltd is a renowned and respected reproductive healthcare provider, with a strong reputation and track record in the industry.

The company has built a recognized brand name and enjoys a significant market presence, providing a competitive advantage in attracting patients and healthcare professionals.

Monash IVF Group offers a broad range of reproductive services, including fertility treatments, genetic screening, donor programs, and specialized diagnostic procedures. This extensive service offering caters to a wide range of patient needs.

Weaknesses

Monash IVF Group's primary revenue stream comes from assisted reproductive technology, making the company vulnerable to any decline in demand or changes in government regulations related to this field.

The reproductive healthcare industry is subject to strict regulations and oversight. Any changes in regulations, compliance requirements, or licensing conditions may impact the company's operations and financial performance.

The cost of reproductive treatments and associated procedures can be relatively high, making it less accessible for certain individuals or causing potential financial strain on patients.

Opportunities

There is an increasing demand for reproductive services due to various factors such as delayed pregnancies, changing lifestyles, and rising infertility rates. Monash IVF Group can leverage this growth opportunity by expanding its service offerings and geographic reach.

Advancements in reproductive technology and genetic testing provide opportunities for Monash IVF Group to enhance its offerings, improve success rates, and develop innovative solutions to address patients' needs.

Threats

The reproductive healthcare industry is highly competitive, with numerous local and international providers. Monash IVF Group faces the risk of losing market share to competitors offering similar services or attractive pricing strategies.

Fluctuations in the economy, changes in healthcare funding, and insurance coverage can impact demand for reproductive services, potentially affecting Monash IVF Group's financial performance.

Reproductive healthcare involves sensitive ethical and legal considerations such as embryo storage, surrogacy agreements, and genetic manipulation. Non-compliance or controversies related to these areas could harm the company's reputation and create legal challenges.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Monash IVF Group Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Monash IVF Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Monash IVF Group shares outstanding

The number of shares was Monash IVF Group in 2024 — This indicates how many shares 389.635 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Monash IVF Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Monash IVF Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Monash IVF Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Monash IVF Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Monash IVF Group dividend history and estimates

In 2024, Monash IVF Group paid a dividend amounting to 0.07 AUD. Dividend means that Monash IVF Group distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Monash IVF Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Monash IVF Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Monash IVF Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Monash IVF Group Dividend History

DateMonash IVF Group Dividend
2027e0.07 AUD
2026e0.07 AUD
2025e0.07 AUD
20240.07 AUD
20230.06 AUD
20220.06 AUD
20210.06 AUD
20200.03 AUD
20190.08 AUD
20180.08 AUD
20170.12 AUD
20160.11 AUD
20150.09 AUD

Monash IVF Group dividend payout ratio

In 2024, Monash IVF Group had a payout ratio of 107.44%. The payout ratio indicates the percentage of the company's profits that Monash IVF Group distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Monash IVF Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Monash IVF Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Monash IVF Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Monash IVF Group Payout Ratio History

DateMonash IVF Group Payout ratio
2027e108.36 %
2026e105.27 %
2025e112.38 %
2024107.44 %
202396 %
2022133.71 %
202192.61 %
202061.67 %
2019101.87 %
201894.63 %
2017100.29 %
201699.77 %
2015107.79 %
201496 %
201396 %
201296 %
201196 %
201096 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Monash IVF Group.

Monash IVF Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.04 AUD0.04 AUD (-3.55 %)2024 Q4
12/31/20230.04 AUD0.04 AUD (-3.55 %)2024 Q2
6/30/20230.03 AUD0.03 AUD (2.17 %)2023 Q4
12/31/20220.03 AUD0.03 AUD (5.61 %)2023 Q2
6/30/20220.02 AUD0.02 AUD (13.86 %)2022 Q4
12/31/20210.03 AUD0.03 AUD (12.21 %)2022 Q2
6/30/20210.03 AUD0.03 AUD (14.62 %)2021 Q4
12/31/20200.04 AUD0.03 AUD (-25.74 %)2021 Q2
6/30/20200.01 AUD0.02 AUD (91.49 %)2020 Q4
6/30/20190.05 AUD0.04 AUD (-14.92 %)2019 Q4
1

Eulerpool ESG Scorecard© for the Monash IVF Group stock

Eulerpool World ESG Rating (EESG©)

63/ 100

🌱 Environment

68

👫 Social

80

🏛️ Governance

42

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees92
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Monash IVF Group shareholders

%
Name
Stocks
Change
Date
6.18519 % Tribeca Investment Partners Pty Ltd.24,099,3504,623,1618/22/2024
5.12862 % Argo Investments Limited19,982,64609/28/2023
4.98460 % Challenger Managed Investments Ltd.19,421,478-1,882,4495/15/2024
4.72395 % Regal Partners Limited18,405,910-261,89211/30/2023
4.54919 % Washington H Soul Pattison Pty. Ltd.17,725,000-679,4509/28/2023
2.45065 % DFA Australia Ltd.9,548,48127,4958/31/2024
1.57660 % Norges Bank Investment Management (NBIM)6,142,8941,428,6986/30/2024
1.51936 % Vanguard Investments Australia Ltd.5,919,86409/30/2024
1.38408 % Dimensional Fund Advisors, L.P.5,392,78508/31/2024
1.07606 % QVG Capital Pty Ltd.4,192,6444,192,6444/30/2024
1
2
3
4
...
5

Monash IVF Group Executives and Management Board

Mr. Michael Knaap

Monash IVF Group Chief Executive Officer, Managing Director, Executive Director (since 2015)
Compensation 1.04 M AUD

Mr. Malik Jainudeen

Monash IVF Group Group Chief Financial Officer, Company Secretary (since 2019)
Compensation 455,492 AUD

Mr. Hamish Hamilton

Monash IVF Group Chief Operating Officer (since 2020)
Compensation 448,167 AUD

Dr. Richard Henshaw

(83)
Monash IVF Group Executive Director
Compensation 343,967 AUD

Mr. Richard Davis

(66)
Monash IVF Group Non-Executive Independent Chairman of the Board
Compensation 168,273 AUD
1
2

Monash IVF Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,680,82-0,140,580,710,81
SupplierCustomer0,360,890,53-0,61-0,23-0,62
SupplierCustomer0,360,090,21-0,71-0,630,48
SupplierCustomer0,240,940,39-0,40-0,730,64
SupplierCustomer0,210,48-0,29-0,68-0,810,34
SupplierCustomer0,05-0,130,070,510,660,74
SupplierCustomer 0,320,14-0,70-0,680,57
SupplierCustomer-0,360,650,26-0,71-0,750,49
1

Most common questions regarding Monash IVF Group

What values and corporate philosophy does Monash IVF Group represent?

Monash IVF Group Ltd represents values of excellence, innovation, and patient-centered care. With a corporate philosophy focused on fulfilling the dreams of parenthood, Monash IVF Group Ltd is dedicated to providing cutting-edge fertility treatments and personalized support to couples and individuals. By leveraging its extensive experience and technological advancements, the company strives to deliver superior reproductive medicine services. Monash IVF Group Ltd maintains its commitment to the highest ethical standards, transparency, and fostering a compassionate and inclusive environment for its patients.

In which countries and regions is Monash IVF Group primarily present?

Monash IVF Group Ltd primarily operates in Australia and Malaysia. Australia is its main market, where it has multiple clinics located across the country. Additionally, the company has a significant presence in Malaysia, offering fertility services through its strategic partnership with Sunfert International. Monash IVF Group Ltd's focus on these countries and regions allows it to provide comprehensive reproductive and fertility services to patients, including in vitro fertilization (IVF), genetic testing, and other related treatments.

What significant milestones has the company Monash IVF Group achieved?

Monash IVF Group Ltd has achieved several significant milestones. The company has a strong track record of delivering high success rates in assisted reproductive technologies such as in vitro fertilization (IVF) and has assisted in the birth of over 30,000 babies. Monash IVF Group Ltd has also pioneered innovative fertility treatments and technologies, including the development of genetic testing for embryos and advancements in egg freezing techniques. The company's commitment to research and clinical excellence has made them a leading player in the fertility industry, earning them a reputation for delivering exceptional patient outcomes and maintaining a position at the forefront of reproductive medicine.

What is the history and background of the company Monash IVF Group?

Monash IVF Group Ltd, founded in 2000, is a leading Australian fertility services provider. Specializing in assisted reproductive technology and treating infertility, the company has a rich history of pioneering advancements. Monash IVF Group Ltd operates a network of fertility clinics, offering comprehensive services such as in vitro fertilization, fertility testing, and sperm and egg donation. With a team of highly skilled specialists, the company is committed to delivering exceptional patient care and achieving strong success rates in fertility outcomes. Monash IVF Group Ltd has grown to become a trusted name in the fertility industry, consistently providing hope and support to individuals and couples seeking to start or expand their families.

Who are the main competitors of Monash IVF Group in the market?

Some of the main competitors of Monash IVF Group Ltd in the market include Virtus Health Limited, Healthscope Limited, and Genea Limited. These companies also operate in the fertility services sector and compete with Monash IVF Group Ltd in providing reproductive and infertility treatments.

In which industries is Monash IVF Group primarily active?

Monash IVF Group Ltd is primarily active in the healthcare and biotechnology industries.

What is the business model of Monash IVF Group?

Monash IVF Group Ltd operates as a leading fertility provider in Australia. The company's business model focuses on offering a comprehensive range of assisted reproductive services. Monash IVF Group specializes in fertility treatments, including in vitro fertilization (IVF), sperm and egg donation, genetic testing, and surrogacy. With a dedicated team of specialists and advanced laboratory facilities, Monash IVF Group aims to help individuals and couples achieve their dream of having a family. By combining cutting-edge technology, personalized care, and research advancements, the company strives to deliver the highest quality fertility care to its patients.

What is the P/E ratio of Monash IVF Group 2025?

The Monash IVF Group P/E ratio is 15.08.

What is the P/S ratio of Monash IVF Group 2025?

The Monash IVF Group P/S ratio is 1.7.

What is the Quality Investing of Monash IVF Group?

The Quality Investing for Monash IVF Group is 5/10.

What is the revenue of Monash IVF Group 2025?

The expected Monash IVF Group revenue is 280.23 M AUD.

How high is the profit of Monash IVF Group 2025?

The expected Monash IVF Group profit is 31.65 M AUD.

What is the business model of Monash IVF Group

Monash IVF Group Ltd is an Australian-based company that specializes in providing assisted reproductive technology (ART) and the investigation and treatment of infertility. The company currently operates multiple fertility clinics and laboratories in Australia and New Zealand. The company offers a wide range of reproductive and fertility services that focus on meeting the specific needs and requirements of each customer. This includes in-vitro fertilization (IVF), intrauterine insemination (IUI), sperm and egg donation, as well as preimplantation diagnosis (PID) and genetic testing. Monash IVF Group has also specialized in researching and developing new technological approaches for assisted reproduction. This includes an extensive research program that focuses on investigating factors that influence fertility, such as lifestyle factors, environmental influences, and genetic predispositions. Another important aspect of the company is the education of doctors, nurses, and other professionals in assisted reproduction. Monash IVF Group offers a variety of courses, training, and workshops to constantly improve and develop knowledge and skills in the field of assisted reproductive technologies. In addition to its clinical services and research program, Monash IVF Group also operates its own diagnostic laboratory that offers a wide range of tests for diagnosing infertility. This includes hormone analysis, semen analysis, and genetic testing. The company is also able to extend its services to international customers. Monash IVF Group has a strong presence in Asia and currently operates clinics in Malaysia and Singapore. Overall, Monash IVF Group has a comprehensive business model that focuses on providing high-quality reproductive and fertility services, conducting innovative research programs, educating professionals, and expanding international markets. The company is well-positioned to grow its customer base and expand its range of services and products to meet the changing demands in the field of assisted reproductive technology.

What is the Monash IVF Group dividend?

Monash IVF Group pays a dividend of 0.06 AUD distributed over payouts per year.

How often does Monash IVF Group pay dividends?

The dividend cannot currently be calculated for Monash IVF Group or the company does not pay out a dividend.

What is the Monash IVF Group ISIN?

The ISIN of Monash IVF Group is AU000000MVF3.

What is the Monash IVF Group WKN?

The WKN of Monash IVF Group is A116LZ.

What is the Monash IVF Group ticker?

The ticker of Monash IVF Group is MVF.AX.

How much dividend does Monash IVF Group pay?

Over the past 12 months, Monash IVF Group paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 5.83 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.07 AUD.

What is the dividend yield of Monash IVF Group?

The current dividend yield of Monash IVF Group is 5.83 %.

When does Monash IVF Group pay dividends?

Monash IVF Group pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Monash IVF Group?

Monash IVF Group paid dividends every year for the past 13 years.

What is the dividend of Monash IVF Group?

For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 5.67 %.

In which sector is Monash IVF Group located?

Monash IVF Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Monash IVF Group from 10/11/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 9/5/2024.

When did Monash IVF Group pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of Monash IVF Group in the year 2024?

In the year 2024, Monash IVF Group distributed 0.063 AUD as dividends.

In which currency does Monash IVF Group pay out the dividend?

The dividends of Monash IVF Group are distributed in AUD.

All fundamentals about Monash IVF Group

Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.